PSI

   |   

   |   

   |   

   |   


Home PSI About Us Full Service Contract Research Organization (CRO) Global Reach On-Time Enrollment Therapeutic Excellence Contract Research Organization (CRO) News

Clinical Trial News     |     Social Media     |     PSI Newsletters     |     PSI Newsletter Articles

Contract Research Organization (CRO) News
You are here:   Home > News > Clinical Trial News
Email Page Print Page

Week 19

  • PSI launched a phase III study of a novel antineoplastic agent in patients with locally advanced head and neck cancer.
  • PSI initiated enrollment in a phase III study of a novel dialysis product in patients with chronic kidney disease.
  • PSI met an interim enrollment objective of 100 randomized patients in phase III study of a novel antiviral in chronic hepatitis C.



About PSI Full Service CRO Global Reach On-Time Enrollment Therapeutic Excellence News
Full Name
Email
Details

© PSI, 1995-2012. All rights reserved. | Terms of Access | Disclaimer | Privacy Policy | Sitemap

PSI on Xing PSI on Twitter PSI on Facebook PSI on Linkedin News Archives